The complex microenvironment of wounds, along with challenges such as microbial infections, tissue damage, and inflammatory responses during the healing process, renders wound repair a complex medical issue. Owing to their ease of administration, effective outcomes, and painless application, biomacromolecule-based wound dressings have become a focal point in current clinical research. In recent years, hydrogels, microneedles, and electrospun nanofibers have emerged as three novel types of wound dressings. By influencing various stages of healing, they have notably enhanced chronic wound healing outcomes and hold considerable potential for wound repair applications. This review describes the preparation methods, classification, and applications of hydrogels, microneedles, and electrospun nanofibers around the various stages of wound healing, clarifying the healing-promoting mechanisms and characteristics of the three methods in different stages of wound healing. Building upon this foundation, we further introduce smart responsiveness, highlighting the application of stimuli-responsive wound dressings in dynamic wound management, aiming to provide insights for future research.

Cholesteryl ester transfer protein (CETP) has been identified as a potential target for cardiovascular disease (CVD) for its important role in the reverse cholesteryl transfer (RCT) process. In our previous work, compound 5 was discovered as a moderate CETP inhibitor. The replacement of the amide linker by heterocyclic aromatics and then a series of N,N-substituted-4-arylthiazole-2-methylamine derivatives were designed by utilizing a conformational restriction strategy. Thirty-six compounds were synthesized and evaluated for their CETP inhibitory activities. Structure-activity relationship studies indicate that electron donor groups substituted ring A, and electron-withdrawing groups at the 4-position of ring B were critical for potency. Among these compounds, compound 30 exhibited excellent CETP inhibitory activity (IC₅₀ = 0.79 ± 0.02 μM) in vitro and showed an acceptable metabolic stability.

N,N-Substituted amine derivatives were designed by utilizing a bioisosterism strategy. Consequently, twenty-two compounds were synthesized and evaluated for their inhibitory activity against CETP. Structure-activity relationship (SAR) studies indicate that hydrophilic groups at the 2-position of the tetrazole and 3,5-bistrifluoromethyl groups on the benzene ring provide important contributions to the potency. Among these compounds, compound 17 exhibited excellent CETP inhibitory activity (IC₅₀ = 0.38 ± 0.08 μM) in vitro. Furthermore, compound 17 was selected for an in vitro metabolic stability study.